What is the Nifty Pharma Index value today?
The latest value of Nifty Pharma Index is 22169.80 as of 7th November 2025.What is the shareholder returns of Nifty Pharma Index Index?
The Nifty Pharma Index has given the following returns in the past:- Past 1 week | -0.00%
- Past 1 month | 2.00%
- Past 3 months | 2.24%
- Past 6 months | 3.30%
- Past 1 year | -1.59%
- Past 3 years | 67.57%
- Past 5 years | 89.90%
What is the 52 week high value of Nifty Pharma Index?
The 52 week high value of Nifty Pharma Index is 23604.45, as of 7th November 2025.What is the 52 week low value of Nifty Pharma Index?
The 52 week low value of Nifty Pharma Index is 19121.10, as of 7th November 2025.What are the components of Nifty Pharma Index?
The components of Nifty Pharma Index, along with their weightage, are as follows -- Sun Pharmaceutical Industries Ltd | 22.96%
- Divi's Laboratories Ltd | 10.79%
- Cipla Ltd | 10.72%
- Dr Reddy's Laboratories Ltd | 9.05%
- Lupin Ltd | 6.10%
Nifty Pharma Index Today
NIFTY PHARMA Share Price
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ETFs tracking NIFTY PHARMA
PHARMABEES
NIFTY PHARMA Performance & Key Metrics
NIFTY PHARMA Performance & Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 35.50 | 5.31 | 0.72% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 3.64% | 20 | 1 |
About NIFTY PHARMA
About NIFTY PHARMA
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY PHARMA 1D return-0.36% | 0.36% | -0.36% | 100.00% | Free float Mcap784.61 Weight100.00% | |
ABBOTINDIA 2.27% Return attribution-0.04% | 2.27% | -0.04% | 1.91% | 14.98 Weight1.91% | |
ALKEM 0.44% Return attribution0.01% | 0.44% | 0.01% | 3.01% | 23.65 Weight3.01% | |
AJANTPHARM 1.74% Return attribution-0.02% | 1.74% | -0.02% | 1.35% | 10.60 Weight1.35% | |
BIOCON 1.25% Return attribution-0.04% | 1.25% | -0.04% | 2.92% | 22.91 Weight2.92% | |
AUROPHARMA 1.47% Return attribution-0.06% | 1.47% | -0.06% | 3.82% | 29.96 Weight3.82% | |
DRREDDY 0.02% Return attribution0.00% | 0.02% | 0.00% | 9.05% | 70.99 Weight9.05% | |
ZYDUSLIFE 0.79% Return attribution0.02% | 0.79% | 0.02% | 3.00% | 23.57 Weight3.00% | |
DIVISLAB 3.30% Return attribution-0.36% | 3.30% | -0.36% | 10.79% | 84.66 Weight10.79% | |
CIPLA 0.28% Return attribution0.03% | 0.28% | 0.03% | 10.72% | 84.10 Weight10.72% | |
GLENMARK 0.06% Return attribution0.00% | 0.06% | 0.00% | 3.30% | 25.85 Weight3.30% | |
IPCALAB 1.03% Return attribution0.02% | 1.03% | 0.02% | 2.34% | 18.38 Weight2.34% | |
J B Chemicals and Pharmaceuticals Ltd JBCHEPHARM 0.66% Return attribution0.01% | 0.66% | 0.01% | 1.77% | 13.87 Weight1.77% | |
LUPIN 0.83% Return attribution0.05% | 0.83% | 0.05% | 6.10% | 47.83 Weight6.10% | |
LAURUSLABS 0.24% Return attribution0.01% | 0.24% | 0.01% | 4.58% | 35.97 Weight4.58% | |
Sun Pharmaceutical Industries Ltd SUNPHARMA 0.33% Return attribution0.07% | 0.33% | 0.07% | 22.96% | 180.14 Weight22.96% | |
TORNTPHARM 0.75% Return attribution0.03% | 0.75% | 0.03% | 4.54% | 35.63 Weight4.54% | |
WOCKPHARMA 1.15% Return attribution-0.02% | 1.15% | -0.02% | 1.36% | 10.69 Weight1.36% | |
GLAND 1.88% Return attribution-0.04% | 1.88% | -0.04% | 1.88% | 14.78 Weight1.88% | |
PPLPHARMA 0.09% Return attribution-0.00% | 0.09% | -0.00% | 1.53% | 12.01 Weight1.53% | |
MANKIND 2.05% Return attribution-0.06% | 2.05% | -0.06% | 3.06% | 24.03 Weight3.06% |
ETFs tracking NIFTY PHARMA Index
ETFs tracking NIFTY PHARMA Index
| ETFs | Price | Liquidity | Expense ratio | Tracking error | |
|---|---|---|---|---|---|
PHARMABEES — | — | High | 0.21% | 0.01% |
NIFTY PHARMA Events
NIFTY PHARMA Events
Dividends
Corp. Actions
Announcements
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
NIFTY PHARMA Upcoming Dividends
NIFTY PHARMA Upcoming Dividends
No upcoming dividends are available
NIFTY PHARMA Past Dividends
NIFTY PHARMA Past Dividends
Cash DividendAJANTPHARM
AJANTPHARMEx DateEx DateNov 10, 2025
Interim 1
Interim 1 | Div/Share: ₹28.00
Dividend/Share
₹28.00
Ex DateEx Date
Nov 10, 2025
Cash DividendLAURUSLABS
LAURUSLABSEx DateEx DateOct 31, 2025
Interim
Interim | Div/Share: ₹0.80
Dividend/Share
₹0.80
Ex DateEx Date
Oct 31, 2025
Cash DividendGLENMARK
GLENMARKEx DateEx DateOct 3, 2025
Interim
Interim | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Oct 3, 2025
Cash DividendGLENMARK
GLENMARKEx DateEx DateSep 15, 2025
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2025
Cash DividendGLAND
GLANDEx DateEx DateAug 14, 2025
Final
Final | Div/Share: ₹18.00
Dividend/Share
₹18.00
Ex DateEx Date
Aug 14, 2025
NIFTY PHARMA News & Opinions
NIFTY PHARMA News & Opinions
Articles & Videos
Simply Put: Pharma stocks & product review cycles
1 week ago•The Hindu Businessline
Drug cos forging data for approval, mislabelling brands to be barred
1 week ago•Economic Times
Indian Pharma Sector Witnesses Robust Deal Momentum Valued At $3.5 Billion In Q3 2025
1 week ago•Free Press Journal
‘This is a racket’: Hawley torches Big Pharma over high drug costs, says, ‘US taxpayer subsidizing…’
2 weeks ago•Economic Times
Torrent Pharma shares in focus after CCI clears Rs 19,500 crore acquisition of JB Chemicals
2 weeks ago•Economic Times
Sensex Today | Stock Market LIVE Updates: GIFT Nifty signals a gap-up start; Asian shares trade lower - The Economic Times
2 weeks ago•Economic Times
CCI clears Torrent Pharma’s proposal to buy stake in JB Chemicals
2 weeks ago•Economic Times
